AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CYduct Diagnostics, Inc.

$1 +$0.80 (+392.37%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$1
Day Range
$1 - $1
Year Range
$0.2$2.9
Market Cap
5.24M
AVG Volume
1.79K
Trailing/Forward PE
-14.97/-
PEG ratio
-1.05
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
050K100K150K2021202220232024
CYDX Revenue (USD) by year
PeriodRevenue (USD)
202470.69K
202384.48K
2022119.34K
202194.05K
Net Income (USD)
-600K-400K-200K02021202220232024
CYDX Net Income (USD) by year
PeriodNet Income (USD)
2024-409.84K
2023-416.13K
2022-472.74K
2021-420.49K
Operating Income (USD)
-600K-400K-200K02021202220232024
CYDX Operating Income (USD) by year
PeriodOperating Income (USD)
2024-363.22K
2023-376.99K
2022-441.25K
2021-403.56K
EBITDA (USD)
-600K-400K-200K02021202220232024
CYDX EBITDA (USD) by year
PeriodEBITDA (USD)
2024-359.44K
2023-377K
2022-325.91K
2021-403.56K
Cash Flows (USD)
-300K-200K-100K02021202220232024
CYDX Cash Flows (USD) by year
PeriodCash Flows (USD)
2024-71.98K
2023-174.83K
2022-266.85K
2021-127.73K
EPS (USD)
-0.1-0.08-0.05-0.03-02021202220232024
CYDX EPS (USD) by year
PeriodEPS (USD)
2024-0.08
2023-0.08
2022-0.09
2021-0.08
Expenses (USD)
0200K400K600KSG&ACapex2021202220232024
CYDX Expenses (USD) by year
PeriodExpenses (USD)
2024406.24K
2023433K
2022524.65K
2021467.06K
Cash & Debt (USD)
0200K400K600K800KCashLong Term DebtShort Term Debt2021202220232024
CYDX Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20241.21K
202329.8K
202254.83K
2021271.68K
Debt ratios
-0.5-0.2500.250.50.752024
CYDX Debt ratios by year
PeriodDebt ratios
2024-0.49
Margins
0%20%40%60%80%2021202220232024
CYDX Margins by year
PeriodMargins
202466.2%
202366.28%
202269.89%
202167.53%
Return on Capital
0%10%20%30%2021202220232024
CYDX Return on Capital by year
PeriodReturn on Capital
202414.59%
202317.37%
202223.36%
202127.12%
Shares Outstanding
02M4M6M2021202220232024
CYDX Shares Outstanding by year
PeriodShares Outstanding
20245.24M
20235.24M
20225.14M
20215.14M
Book Value Per Share (USD)
-0.6-0.4-0.2-02021202220232024
CYDX Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2024-0.54
2023-0.46
2022-0.39
2021-0.3
Total Assets (USD)
0100K200K300K2021202220232024
CYDX Total Assets (USD) by year
PeriodTotal Assets (USD)
202437.68K
202354.75K
202280.85K
2021296.67K
Free Cash Flow Yield
-30%-20%-10%0%10%med -6.76%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CYDX Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 260.2%
Sep 260.16%
Aug 260.17%
Aug 260.17%
Aug 260.09%
Aug 260.09%
Jul 260.09%
Jul 260.07%
Jul 260.07%
Jul 260.13%
Jul 260.47%
Jun 26-0.85%
Jun 26-0.88%
Jun 26-0.88%
Jun 26-0.88%
May 26-0.88%
May 26-0.88%
May 26-0.58%
May 26-0.58%
May 26-0.58%
Apr 26-0.58%
Apr 26-0.58%
Apr 26-0.58%
Apr 26-0.57%
Mar 26-1.39%
Mar 26-1.23%
Mar 26-1.23%
Mar 26-1.17%
Feb 26-1.03%
Feb 26-0.89%
Feb 26-0.89%
Feb 26-1.4%
Jan 26-1.09%
Jan 26-0.32%
Jan 26-0.32%
Jan 26-4.27%
Jan 26-4.27%
Dec 25-6.76%
Dec 25-6.76%
Dec 25-6.76%
Dec 25-6.76%
Nov 25-6.76%
Nov 25-6.76%
Nov 25-6.76%
Nov 25-6.76%
Oct 25-6.76%
Oct 25-6.83%
Oct 25-3.14%
Oct 25-3.14%
Oct 25-5.09%
Sep 25-8.67%
Sep 25-8.08%
Sep 25-8.08%
Sep 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Aug 25-8.08%
Jul 25-8.08%
Jul 25-8.08%
Jul 25-8.08%
Jul 25-8.08%
Jun 25-9.82%
Jun 25-9.82%
Jun 25-4.97%
Jun 25-4.97%
May 25-5.07%
May 25-12.19%
May 25-12.19%
May 25-12.19%
May 25-12.19%
Apr 25-12.19%
Apr 25-12.25%
Apr 25-12.25%
Apr 25-12.25%
Mar 25-14.71%
Mar 25-14.86%
Mar 25-14.86%
Mar 25-14.86%
Feb 25-14.86%
Feb 25-14.86%
Feb 25-14.86%
Feb 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Jan 25-19.54%
Dec 24-21.93%
Dec 24-21.95%
Dec 24-21.95%
Dec 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Nov 24-22.08%
Oct 24-22.08%
Oct 24-23.79%
Price to Sales
0100200300med 18.2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CYDX Price to Sales by year
PeriodPrice to Sales
Sep 2679.78
Sep 2698.93
Aug 2693.34
Aug 2693.34
Aug 26165.94
Aug 26165.94
Jul 26165.94
Jul 26215.41
Jul 26215.41
Jul 26118.08
Jul 2633.51
Jun 2637.13
Jun 2635.63
Jun 2635.63
Jun 2635.63
May 2635.63
May 2635.63
May 2653.93
May 2653.93
May 2653.93
Apr 2653.93
Apr 2653.93
Apr 2653.93
Apr 2655.35
Mar 2647.53
Mar 2653.74
Mar 2653.74
Mar 2656.53
Feb 2664.12
Feb 2674.41
Feb 2674.41
Feb 2647.08
Jan 2660.74
Jan 26204.98
Jan 26204.98
Jan 2615.42
Jan 2615.42
Dec 2515.06
Dec 2515.06
Dec 2515.06
Dec 2515.06
Nov 2515.06
Nov 2515.06
Nov 2515.06
Nov 2515.06
Oct 2515.06
Oct 2514.91
Oct 2532.47
Oct 2532.47
Oct 2520.02
Sep 2516.96
Sep 2518.2
Sep 2518.2
Sep 2518.2
Aug 2518.2
Aug 2518.2
Aug 2518.2
Aug 2518.2
Aug 2518.2
Jul 2518.2
Jul 2518.2
Jul 2518.2
Jul 2518.2
Jun 2517.2
Jun 2517.2
Jun 2533.98
Jun 2533.98
May 2533.3
May 2513.86
May 2513.86
May 2513.86
May 2513.86
Apr 2513.86
Apr 2513.79
Apr 2513.79
Apr 2513.79
Mar 2515.12
Mar 2514.96
Mar 2514.96
Mar 2514.96
Feb 2514.96
Feb 2514.96
Feb 2514.96
Feb 2511.38
Jan 2511.38
Jan 2511.38
Jan 2511.38
Jan 2511.38
Jan 2511.38
Dec 249.44
Dec 249.43
Dec 249.43
Dec 249.37
Nov 249.37
Nov 249.37
Nov 249.37
Nov 249.37
Nov 249.37
Oct 249.37
Oct 248.7
Price/Operating Cashflow
050010001500med 753.42Jul 26Jul 26Jul 26Aug 26Aug 26Sep 26
CYDX Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 26509.07
Sep 26631.24
Aug 26595.61
Aug 26595.61
Aug 261058.86
Aug 261058.86
Jul 261058.86
Jul 261374.48
Jul 261374.48
Jul 26753.42
Jul 26213.81
CYduct Diagnostics, Inc.
CYDX
Stockpicker

Video analysis: CYDX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.